IMMUNO-BIOLOGICAL LABORATORIES CO financial statements, including revenue, expenses, and profit
The total revenue of 4570 for the last quarter is 235.99 M JPY, and it's 10.01% higher compared to the previous quarter. The net income of Q3 24 is 61.85 M JPY.